Clinical and prognostic data were additionally analyzed, revealing that higher TRIB3 levels were associated with higher TNM staging and a higher pathological Fuhrman grade among patients with RCC, together with shorter postoperative overall survival (OS) (Fig. 1F–H). This evidence concerns the gene TRIB3 and renal cell carcinoma.